- Home
- HFBL vs DXR Comparison
HFBL vs DXR Comparison
Compare HFBL & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- DXR
- Stock Information
- Founded
- HFBL 1924
- DXR 1970
- Country
- HFBL United States
- DXR United States
- Employees
- HFBL N/A
- DXR N/A
- Industry
- HFBL Savings Institutions
- DXR Medical/Dental Instruments
- Sector
- HFBL Finance
- DXR Health Care
- Exchange
- HFBL Nasdaq
- DXR Nasdaq
- Market Cap
- HFBL 39.4M
- DXR 37.6M
- IPO Year
- HFBL N/A
- DXR N/A
- Fundamental
- Price
- HFBL $12.82
- DXR $8.22
- Analyst Decision
- HFBL
- DXR Strong Buy
- Analyst Count
- HFBL 0
- DXR 1
- Target Price
- HFBL N/A
- DXR $24.75
- AVG Volume (30 Days)
- HFBL 625.0
- DXR 6.8K
- Earning Date
- HFBL 01-27-2025
- DXR 01-01-0001
- Dividend Yield
- HFBL 4.06%
- DXR N/A
- EPS Growth
- HFBL N/A
- DXR N/A
- EPS
- HFBL 1.09
- DXR 0.35
- Revenue
- HFBL $19,727,000.00
- DXR $154,205.00
- Revenue This Year
- HFBL N/A
- DXR N/A
- Revenue Next Year
- HFBL N/A
- DXR N/A
- P/E Ratio
- HFBL $11.80
- DXR $24.39
- Revenue Growth
- HFBL N/A
- DXR N/A
- 52 Week Low
- HFBL $10.60
- DXR $7.19
- 52 Week High
- HFBL $14.60
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- HFBL 49.13
- DXR 49.04
- Support Level
- HFBL $12.55
- DXR $8.01
- Resistance Level
- HFBL $13.00
- DXR $8.50
- Average True Range (ATR)
- HFBL 0.02
- DXR 0.31
- MACD
- HFBL 0.04
- DXR 0.09
- Stochastic Oscillator
- HFBL 28.72
- DXR 72.98
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.